Private Equity Firm
Appears in 1 story
Former co-controlling shareholder of Clario; exited via sale to Thermo Fisher
Thermo Fisher Scientific, one of the world's largest scientific instrumentation companies, closed its $8.875 billion cash purchase of Clario Holdings on March 24, 2026. Clario provides the digital tools that pharmaceutical companies use to collect patient data during clinical trials — technology that has contributed to roughly 70 percent of drugs approved by the Food and Drug Administration (FDA) over the past decade. The deal, first announced in October 2025, also includes up to $525 million in additional payments tied to Clario's near-term performance, bringing the total potential price to approximately $9.4 billion.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
